Liraglutide, a once-daily human GLP-1 analogue, reduces body weight and improves obesity-related risk factors in obese non-diabetic subjects: A randomised placebo-controlled trial

Research output: Contribution to journalConference abstract in journalResearch

  • Astrup, Arne
  • Luc van Gaal
  • Aila Rissanen
  • Leo Niskanen
  • Mazin Al Hakim
  • Jesper Madsen
  • Mads Frederik Rasmussen
  • Stephan Rössner
Original languageEnglish
JournalObesity
Volume16
Issue numbersuppl 1
Pages (from-to)S64
Number of pages1
ISSN1930-7381
Publication statusPublished - 2008
EventThe Obesity Society Annual Scientific Meeting 2008 - Phoenix, United States
Duration: 3 Oct 20087 Oct 2008

Conference

ConferenceThe Obesity Society Annual Scientific Meeting 2008
CountryUnited States
CityPhoenix
Period03/10/200807/10/2008

ID: 10732791